Tim Seidler

ORCID: 0000-0002-6158-5087
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Cardiac electrophysiology and arrhythmias
  • Cardiovascular Function and Risk Factors
  • Ion channel regulation and function
  • Cardiac Arrest and Resuscitation
  • Mechanical Circulatory Support Devices
  • Cardiac Structural Anomalies and Repair
  • Cardiac Imaging and Diagnostics
  • Signaling Pathways in Disease
  • Cardiomyopathy and Myosin Studies
  • Infective Endocarditis Diagnosis and Management
  • Pulmonary Hypertension Research and Treatments
  • Heart Failure Treatment and Management
  • Acute Myocardial Infarction Research
  • Cardiovascular Effects of Exercise
  • Advanced MRI Techniques and Applications
  • Neuroscience and Neuropharmacology Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac pacing and defibrillation studies
  • Cardiac Fibrosis and Remodeling
  • Coronary Interventions and Diagnostics
  • Pluripotent Stem Cells Research
  • Medical Imaging Techniques and Applications
  • Cardiac Ischemia and Reperfusion
  • Aortic Disease and Treatment Approaches

University of Göttingen
2016-2025

Justus-Liebig-Universität Gießen
2024-2025

Kerckhoff Klinik
2024-2025

German Centre for Cardiovascular Research
2017-2025

Sequoia (United States)
2024

SEQUOIA (Italy)
2024

Universitätsmedizin Göttingen
2014-2024

Nephrologisches Zentrum Goettingen
2020-2022

Amsterdam UMC Location University of Amsterdam
2019

King's College London
2017

Iacopo Olivotto Artur Oręziak Roberto Barriales‐Villa Theodore P. Abraham Ahmad Masri and 94 more Pablo García‐Pavía Sara Saberi Neal K. Lakdawala Matthew T. Wheeler Anjali Owens Miloš Kubánek Wojciech Wojakowski Morten K. Jensen Juan R. Gimeno Jonathan Myers Jonathan Myers Sheila M. Hegde Scott D. Solomon Amy J. Sehnert David Zhang Wanying Li Mondira Bhattacharya Jay M. Edelberg Cynthia Burstein Waldman Steven J. Lester Carolyn Y. Ho Carolyn Y. Ho Jozef Bartúnek Jozef Bartúnek Antoine Bondue Emeline M. Van Craenenbroeck Miloš Kubánek David Zemánek Morten K. Jensen Jens Mogensen Jens Jakob Thune Philippe Charron Albert Hagège Olivier Lairez Jean‐Noël Trochu Christoph Axthelm H DUENGEN Norbert Frey Veselin Mitrović Michael Preusch Jeanette Schulz‐Menger Tim Seidler Michael Arad Majdi Halabi Amos Katz Daniel Monakier Offir Paz Samuel Viskin Donna R. Zwas Iacopo Olivotto Hans‐Peter Brunner‐La Rocca Michelle Michels Dariusz Dudek Zofia Oko‐Sarnowska Artur Oręziak Wojciech Wojakowski Nuno Cardim Helder Pereira Roberto Barriales‐Villa Pablo García Pavía Juan Gimeno Blanes Rafael Hidalgo Urbano Leonardo Mejia Rincon Perry Elliott Zaheer Yousef Theodore P. Abraham Jonathan Myers Paulino Álvarez Richard G. Bach Richard C. Becker Lubna Choudhury David Fermin Jozef Bartúnek John L. Jefferies Christopher M. Kramer Neal K. Lakdawala Steven J. Lester Ali J. Marian Ahmad Masri Matthew J. Maurer Sherif F. Nagueh Anjali Owens David S. Owens Florian Rader Sara Saberi Mark V. Sherrid Jamshid Shirani John D. Symanski Aslan T. Turer Carolyn Y. Ho Omar Wever‐Pinzon Matthew T. Wheeler Timothy C. Wong Mohamad H. Yamani

10.1016/s0140-6736(20)31792-x article EN The Lancet 2020-08-29

Extracorporeal life support (ECLS) is increasingly used in the treatment of infarct-related cardiogenic shock despite a lack evidence regarding its effect on mortality. Download PDF Research Summary. In this multicenter trial, patients with acute myocardial infarction complicated by for whom early revascularization was planned were randomly assigned to receive ECLS plus usual medical (ECLS group) or alone (control group). The primary outcome death from any cause at 30 days. Safety outcomes...

10.1056/nejmoa2307227 article EN New England Journal of Medicine 2023-08-26

Background— Hemodynamic load regulates myocardial function and gene expression. We tested the hypothesis that afterload preload, despite similar average load, result in different phenotypes. Methods Results— Afterload preload were compared mice with transverse aortic constriction (TAC) aortocaval shunt (shunt). Compared sham mice, 6 hours after surgery, systolic wall stress (afterload) was increased TAC (+40%; P <0.05), diastolic (preload) (+277%; <0.05) (+74%; mean total similarly...

10.1161/circulationaha.110.943431 article EN Circulation 2010-08-24

Data assessing the long-term safety and efficacy of mavacamten treatment for symptomatic obstructive hypertrophic cardiomyopathy are needed. The authors sought to evaluate interim results from EXPLORER-Long Term Extension (LTE) cohort MAVA-LTE (A Long-Term Safety Study Mavacamten in Adults Who Have Completed EXPLORER-HCM; NCT03723655). After or placebo withdrawal at end parent EXPLORER-HCM (Clinical Evaluate [MYK-461] With Symptomatic Obstructive Hypertrophic Cardiomyopathy; NCT03470545),...

10.1016/j.jchf.2023.09.028 article EN cc-by-nc-nd JACC Heart Failure 2024-01-01

Long-term safety and efficacy of mavacamten in patients with obstructive hypertrophic cardiomyopathy (HCM) are unknown. MAVA-LTE (NCT03723655) is an ongoing, 5-year, open-label extension study designed to evaluate the long-term effects mavacamten.

10.1093/eurheartj/ehae579 article EN cc-by-nc European Heart Journal 2024-09-01

Abstract Cardiomyocytes can be implanted to remuscularize the failing heart 1–7 . Challenges include sufficient cardiomyocyte retention for a sustainable therapeutic impact without intolerable side effects, such as arrhythmia and tumour growth. We investigated hypothesis that epicardial engineered muscle (EHM) allografts from induced pluripotent stem cell-derived cardiomyocytes stromal cells structurally functionally chronically limiting effects in rhesus macaques. After confirmation of...

10.1038/s41586-024-08463-0 article EN cc-by Nature 2025-01-29

The predominant cardiac Ca2+/calmodulin-dependent protein kinase (CaMK) is CaMKIIdelta. Here we acutely overexpress CaMKIIdeltaC using adenovirus-mediated gene transfer in adult rabbit ventricular myocytes. This circumvents confounding adaptive effects transgenic mice. expression and activation state (autophosphorylation) were increased 5- to 6-fold. Basal twitch contraction amplitude kinetics (1 Hz) not changed versus LacZ expressing However, the contraction-frequency relationship was more...

10.1161/01.res.0000200739.90811.9f article EN Circulation Research 2005-12-23

Abstract Aims Myocardial fibrosis (MF) might represent a key player in pathophysiology of heart failure aortic stenosis (AS). We aimed to assess its impact on left ventricular (LV) remodelling, recovery, and mortality after transcatheter valve implantation (TAVI) different AS subtypes. Methods results One hundred patients with severe were prospectively characterized clinically echocardiographically at baseline (BL), 6 months, 1 year, 2 years following TAVI. Left biopsies harvested...

10.1093/eurheartj/ehaa033 article EN cc-by-nc European Heart Journal 2020-01-14

Right heart catheterization using exercise stress is the reference standard for diagnosis of failure with preserved ejection fraction (HFpEF) but carries risk invasive procedure. We hypothesized that real-time cardiac magnetic resonance (RT-CMR) imaging pathophysiologic data at excellent temporal and spatial resolution may represent a contemporary noninvasive alternative diagnosing HFpEF.The HFpEF-Stress trial (CMR Exercise Stress Testing in HFpEF; URL: https://www.clinicaltrials.gov; Unique...

10.1161/circulationaha.120.051542 article EN Circulation 2021-01-21

Severe tricuspid regurgitation (TR) has limited treatment options and is associated with high morbidity mortality.We evaluated the safety effectiveness of Cardioband valve reconstruction system from ongoing European single-arm, multicentre, prospective TriBAND post-market clinical follow-up study.Eligible patients had chronic symptomatic functional TR despite diuretic therapy were deemed candidates for transcatheter repair by local Heart Team.Sixty-one ≥severe TR. At baseline, 85% in NYHA...

10.4244/eij-d-21-00300 article EN EuroIntervention 2021-11-01

Despite their remarkable performance, deep neural networks remain unadopted in clinical practice, which is considered to be partially due lack explainability. In this work, we apply attribution methods a pre-trained network (DNN) for 12-lead electrocardiography classification open "black box" and understand the relationship between model prediction learned features. We classify data from public set assign "relevance score" each sample of classified signals. This allows analyzing what during...

10.1109/jbhi.2023.3271858 article EN cc-by IEEE Journal of Biomedical and Health Informatics 2023-05-01

Extracorporeal life support (ECLS) has been increasingly used in the treatment of severe infarct-related cardiogenic shock last decade. The randomised ECLS-SHOCK trial demonstrated no benefit early routine use on 30-day all-cause death. We herein present mid-term results. At 1-year follow-up, there were significant differences or cardiovascular mortality, neurologic outcome, recurrent myocardial infarction, repeat revascularisation and rehospitalisations for heart failure between ECLS usual...

10.1093/eurheartj/ehae610 article EN other-oa European Heart Journal 2024-09-02
Derk Frank Éric Durand Sandra Lauck Douglas Muir Mark Spence and 95 more Mariuca Vasa‐Nicotera David A. Wood Francesco Saia Cristóbal A. Urbano-Carrillo Damien Bouchayer Vlad Florin Anton Christophe Saint Etienne Florence Leclercq Vincent Auffret Lluís Asmarats Carlo Di Mario Aurélie Veugeois Jiří Malý Andreas Schober Luis Nombela‐Franco Nikos Werner Joan Antoni Gómez‐Hospital Julia Mascherbauer Giuseppe Musumeci Nicolas Méneveau Thibaud Meurice Felix Mahfoud Federico De Marco Tim Seidler Florian Leuschner Patrick Joly Jean‐Philippe Collet Ferdinand Vogt Emilio Di Lorenzo Elmar Kuhn Vicente Peral Disdier Violetta Hachaturyan Claudia M. Lüske Radka Rakova W.A. Wesselink Jana Kurucova Peter Bramlage Gemma McCalmont Derk Frank Gemma McCalmont Peter Bramlage Claudia M. Lüske Marie Zielinski Daniel Greinert Cornelia Deutsch Violetta Hachaturyan Éric Durand Sandra Lauck Douglas Muir Mark Spence Mariuca Vasa‐Nicotera David A. Wood Francesco Saia Jana Kurucova W.A. Wesselink Radka Rakova Martin Thoenes Cristóbal A. Urbano-Carrillo Carlos Lara García Beatriz Chamorro Damien Bouchayer Jean-Philippe Claudel H. Perrier Viktoria Frebault Vlad Florin Anton Catalina A. Parasca Christophe Saint Etienne Katia Lassouani Florence Leclercq Wassim Zitouni Sonia Soltani Vincent Auffret Rosalie Le Gal Lluís Asmarats Elena Jiménez Xarrié Carlo Di Mario Niccolò Ciardetti Francesco Meucci Aurélie Veugeois Imane Bagdadi Jiří Malý Lenka Kolinova Andreas Schober Georg Delle‐Karth C. Schuster Marie-Christine Leitgeb Luis Nombela‐Franco Esther Bernardo García María Aránzazu Ortega Pozzi Nikos Werner Jürgen Leick Michael Lauterbach Hannah Waschbüsch Joan Antoni Guillem Muntané

Abstract Background and Aims There is significant potential to streamline the clinical pathway for patients undergoing transcatheter aortic valve implantation (TAVI). The purpose of this study was evaluate effect implementing BENCHMARK best practices on efficiency safety TAVI in 28 sites 7 European countries. Methods This a with severe symptomatic stenosis (AS) balloon-expandable valves before after implementation practices. Principal objectives were reduce hospital length stay (LoS)...

10.1093/eurheartj/ehae147 article EN cc-by European Heart Journal 2024-03-30

ABSTRACT Interleukin (IL)‐18 is the interferon‐γ‐inducing factor and has potent proinflammatory activities. IL‐18 been recently implicated in atherosclerotic plaque instability myocardial ischemia‐reperfusion injury. However, it unknown whether expression increased human myocardium or if any role heart failure. We analyzed of IL‐18, its receptor IL‐18Rα, endogenous inhibitor, binding protein (IL‐18BP) tissue from patients with end‐stage failure (ischemic dilated cardiomyopathy) controls by...

10.1096/fj.04-2426fje article EN The FASEB Journal 2004-09-15

Machine learning (ML) is a powerful tool for identifying and structuring several informative variables predictive tasks. Here, we investigated how ML algorithms may assist in echocardiographic pulmonary hypertension (PH) prediction, where current guidelines recommend integrating parameters.In our database of 90 patients with invasively determined artery pressure (PAP) corresponding estimations PAP obtained within 24 hours, trained applied five (random forest classification trees, random...

10.1371/journal.pone.0224453 article EN cc-by PLoS ONE 2019-10-25

Abstract Aims Health data captured by commercially available smart devices may represent meaningful patient‐reported outcome measures (PROMs) in heart failure (HF) patients. The purpose of this study was to test hypothesis evaluating the feasibility a new telemonitoring concept for patients following initial HF hospitalization. Methods and results We designed cardio patient monitoring platform (CPMP) that comprised mobile iOS‐based applications patients' smartphone/smartwatch equivalent...

10.1002/ehf2.12425 article EN cc-by-nc-nd ESC Heart Failure 2019-03-13
Caroline Coats Ahmad Masri Michael E. Nassif Roberto Barriales‐Villa Michael Arad and 95 more Nuno Cardim Lubna Choudhury Brian Claggett Hans‐Dirk Düngen Pablo García‐Pavía Albert Hagège James L. Januzzi Matthew M.Y. Lee Gregory D. Lewis Changsheng Ma Martin S. Maron Zi Michael Miao Michelle Michels Iacopo Olivotto Artur Oręziak Anjali Owens John A. Spertus Scott D. Solomon Jacob Tfelt‐Hansen Marion van Sinttruije Josef Veselka Hugh Watkins Daniel Jacoby Polina German Stephen B. Heitner Stuart Kupfer Justin D. Lutz Fady I. Malik Lisa Meng Amy Wohltman Theodore P. Abraham Yuhui Zhang Haibo Yang Chunli Shao Zuyi Yuan Qingchun Zeng Xiaodong Li Yushi Wang Yan Shu Mulei Chen Ling Tao Xinli Li Jingfeng Wang Zaixin Yu Xiang Cheng Kui Hong David Zemánek Henning Bundgaard Jens Jakob Thune Morten K. Jensen Jens Mogensen Gilbert Habib Philippe Charron Thibault Lhermusier Jean‐Noël Trochu Patricia Réant Damien Logeart Veselin Mitrović Tarek Bekfani Frank Edelmann Tim Seidler Benjamin Meder P. Christian Schulze S. Stoerk Tienush Rassaf Béla Merkely Donna Zfat‐Zwas Majdi Halabi Offir Paz Xavier Piltz Marco Metra Marco Canepa Beatrice Musumeci Michele Emdin Ahmad S. Amin Christian Knackstedt Wojciech Wojakowski Dariusz Dudek Alexandra Toste José Mesquita Bastos Juan R. Gimeno Rafael Jesus Hidalgo Urbano Ana García Álvarez Leonardo Mejia Rincon Tomás Vicente Vera Perry Elliott NHS Greater Glasgow Robert Cooper Liverpool Heart Masliza Mahmod Antonis Pantazis Maite Tome Oregon Health Ali J. Marian David S. Owens

Background Aficamten, a novel cardiac myosin inhibitor, reversibly reduces hypercontractility in obstructive hypertrophic cardiomyopathy. We present prespecified analysis of the pharmacokinetics, pharmacodynamics, and safety aficamten SEQUOIA‐HCM (Safety, Efficacy, Quantitative Understanding Obstruction Impact Aficamten HCM). Methods Results A total 282 patients with cardiomyopathy were randomized 1:1 to daily (5–20 mg) or placebo between February 1, 2022, May 15, 2023. dosing targeted...

10.1161/jaha.124.035993 article EN cc-by-nc-nd Journal of the American Heart Association 2024-07-26

Mitral transcatheter edge-to-edge repair (M-TEER) is a guideline-recommended treatment option for patients with severe symptomatic mitral regurgitation (MR). Outcomes the PASCAL system in post-market setting have not been established. The authors report 30-day and 1-year outcomes from MiCLASP (Transcatheter Repair of Regurgitation Edwards Transcatheter Valve System) European clinical follow-up study. Patients symptomatic, clinically significant MR were prospectively enrolled. primary safety...

10.1016/j.jcin.2024.02.022 article EN cc-by КАРДИОЛОГИЯ УЗБЕКИСТАНА 2024-04-01

Post-cardiac arrest myocardial dysfunction is a common phenomenon after return of spontaneous circulation (ROSC) and contributes to hemodynamic instability low survival rates cardiac arrest. Mild hypothermia for 24 h ROSC has been shown significantly improve neurologic recovery rates. In the present study we investigate influence therapeutic on parameters in resuscitated patients contractility failing human myocardium. We analyzed data from 200 survivors during period. The initial LVEF was...

10.1007/s00392-010-0113-2 article EN cc-by-nc Clinical Research in Cardiology 2010-02-03

Calcineurin/NFAT signaling is involved in multiple aspects of skeletal muscle development and disease. The myogenic basic helix-loop-helix transcription factors, MyoD, myogenin, Myf5, MRF4 specify the lineage. Here we show that calcineurin/NFAT (nuclear factor activated T cells) required for primary myogenesis by transcriptional cooperation with MyoD. myogenin expression differentiating myoblasts, where regulatory MyoD synergistically cooperates NFATc2/c3 at promoter. Using gel shift...

10.1074/jbc.m801297200 article EN cc-by Journal of Biological Chemistry 2008-08-02

Abstract Aims This study was designed to evaluate the safety, tolerability and haemodynamic effects of BMS ‐986231, a novel second‐generation nitroxyl donor with potential inotropic, lusitropic vasodilatory in patients hospitalized decompensated heart failure reduced ejection fraction ( HFrEF ). Methods results Forty‐six were enrolled into four sequential dose‐escalation cohorts this double‐blind, randomized, placebo‐controlled Phase 2a study. Patients baseline pulmonary capillary wedge...

10.1002/ejhf.897 article EN cc-by-nc European Journal of Heart Failure 2017-07-05

ABSTRACT Aims The REDUCE‐LAP II trial demonstrated adverse outcomes after interatrial shunt device (IASD) placement in heart failure with preserved ejection fraction (HFpEF) attributed to latent pulmonary vascular disease (PVD). We hypothesized that exercise stress cardiovascular magnetic resonance (CMR) imaging could provide non‐invasive characterization of cardiac and physiology for improved patient selection. Methods results HFpEF‐Stress prospectively enrolled 75 patients exertional...

10.1002/ejhf.2781 article EN cc-by-nc European Journal of Heart Failure 2023-01-24
Coming Soon ...